Correlation Between Basilea Pharmaceutica and Vaccinex

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Basilea Pharmaceutica and Vaccinex at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Basilea Pharmaceutica and Vaccinex into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Basilea Pharmaceutica AG and Vaccinex, you can compare the effects of market volatilities on Basilea Pharmaceutica and Vaccinex and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Basilea Pharmaceutica with a short position of Vaccinex. Check out your portfolio center. Please also check ongoing floating volatility patterns of Basilea Pharmaceutica and Vaccinex.

Diversification Opportunities for Basilea Pharmaceutica and Vaccinex

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Basilea and Vaccinex is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Basilea Pharmaceutica AG and Vaccinex in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaccinex and Basilea Pharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Basilea Pharmaceutica AG are associated (or correlated) with Vaccinex. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaccinex has no effect on the direction of Basilea Pharmaceutica i.e., Basilea Pharmaceutica and Vaccinex go up and down completely randomly.

Pair Corralation between Basilea Pharmaceutica and Vaccinex

If you would invest  5,283  in Basilea Pharmaceutica AG on October 26, 2024 and sell it today you would earn a total of  0.00  from holding Basilea Pharmaceutica AG or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy74.58%
ValuesDaily Returns

Basilea Pharmaceutica AG  vs.  Vaccinex

 Performance 
       Timeline  
Basilea Pharmaceutica 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Basilea Pharmaceutica AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Basilea Pharmaceutica is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.
Vaccinex 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vaccinex has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Basilea Pharmaceutica and Vaccinex Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Basilea Pharmaceutica and Vaccinex

The main advantage of trading using opposite Basilea Pharmaceutica and Vaccinex positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Basilea Pharmaceutica position performs unexpectedly, Vaccinex can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaccinex will offset losses from the drop in Vaccinex's long position.
The idea behind Basilea Pharmaceutica AG and Vaccinex pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
CEOs Directory
Screen CEOs from public companies around the world